Company Valuation: DIVA Laboratories, Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 1,455 1,572 2,379 2,159 2,244 2,048
Change - 8.06% 51.31% -9.25% 3.94% -8.76%
Enterprise Value (EV) 1 1,128 1,273 2,033 1,630 1,660 1,556
Change - 12.91% 59.64% -19.84% 1.86% -6.24%
P/E 95.4x 72.4x 48.3x 29.4x 24.1x 22.7x
PBR 1.47x 1.59x 2.34x 2.09x 2.13x 1.99x
PEG - 1.7x 0x 0.6x 0.9x -7.22x
Capitalization / Revenue 1.97x 2.21x 2.51x 2.42x 2.6x 2.36x
EV / Revenue 1.53x 1.79x 2.14x 1.82x 1.92x 1.79x
EV / EBITDA 13.1x 37.4x 21.8x 16.2x 14x 14.3x
EV / EBIT 16x 56.3x 24x 17.7x 14.9x 15.2x
EV / FCF -23.5x -47.2x 51.9x 6.92x 16.7x 1,719x
FCF Yield -4.25% -2.12% 1.93% 14.5% 5.99% 0.06%
Dividend per Share 2 0.26 0.37 1 1.25 2 2
Rate of return 1.05% 1.38% 2.47% 3.4% 5.23% 5.73%
EPS 2 0.26 0.37 0.84 1.25 1.59 1.54
Distribution rate 100% 100% 119% 100% 126% 130%
Net sales 1 736.9 712.2 949.2 893.8 862.3 868.8
EBITDA 1 86.03 34.04 93.06 100.3 118.7 109
EBIT 1 70.54 22.6 84.83 92.15 111.2 102.3
Net income 1 17.42 21.86 49.66 73.62 93.66 90.54
Net Debt 1 -327.1 -298.9 -346.1 -529.4 -584.2 -491.1
Reference price 2 24.80 26.80 40.55 36.80 38.25 34.90
Nbr of stocks (in thousands) 58,668 58,668 58,668 58,668 58,668 58,668
Announcement Date 3/31/21 3/28/22 3/29/23 3/20/24 3/13/25 3/26/26
1TWD in Million2TWD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 58.08M
60.61x7.31x25.18x0.74% 135B
27.93x1.22x5.96x1.21% 32.6B
14.55x0.99x5.34x3.47% 14.69B
25.03x1.18x7.5x2.91% 11.81B
15.64x5.24x13.77x3.02% 6.97B
24.27x0.77x7.96x1.41% 5.71B
25.86x0.61x3.11x-.--% 3.44B
Average 27.70x 2.48x 9.83x 1.82% 26.28B
Weighted average by Cap. 47.28x 5.23x 18.61x 1.21%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 4153 Stock
  4. Valuation DIVA Laboratories, Ltd.